MSB Trading - 2019, page-924

Nothing new here with MSB dropping after a quarterly, as we all know the lack of profit and cash burn is a big issue for the blast so not surprising to see a dip every three months after the market is informed.

this next 3 months will be interesting, if the board takes up the offer for the borrowing facility then I would interpret that there is no imminent partnership deal. So would expect the market to react accordingly. Obviously the alternative would be a partnership announcement to fund us into the future which would bump the SP significantly.

does anyone have a date / time for the next teleconference? Would be interesting to hear if SI makes any comments on their plan regarding further loans or keeps tight lipped and continues with the ‘advanced negotiations’ partnership rhetoric. The lack of transparency is getting very frustrating though because this company has potential but don’t keep shareholders well informed. For example we still have no real idea on expectations of timeline for approval of GVHD - it’s now been two weeks since the FDA meeting was announced and the first module was to be submitted ‘shortly’ but no news. And he need to say yes or no as to whether there will be a 12 months read out of the back pain trial - if not that’s fine (the trial is blinded after all) but he should know the answer and tell us rather than evading the question.